Q. Xu et al. / Tetrahedron 66 (2010) 624–630
629
CDCl3)
d
7.722–7.652 (dd, J¼8.4, 27.6 Hz, 4H), 6.470(s,1H), 2.196(s, 3H);
70 eV) m/z: 139 (19), 99 (100), 83 (96), 67 (10), 57 (19), 55 (87), 43
(77), 41 (35); IR (film, cmꢁ1): 2933, 2858, 1755, 1449, 1373, 1221,
1033; Chiralcel OJ-H, Hexane/i-PrOH¼100:0, 0.7 ml/min, 220 nm,
tR¼17.42 min, tR¼20.13 min.
19F NMR (376 MHz, CDCl3)
d
ꢁ62.97 (s, 3F); MS (EI 70 eV) m/z:243(Mþ,
6), 201 (83), 184 (49), 183 (46), 173 (35), 145 (12), 134 (23), 43 (100); IR
(KBr, cmꢁ1): 2945, 1758, 1622, 1420, 1374, 1327, 1215, 1170, 1130, 1068,
1020, 963, 912, 828, 744, 602; HPLC: Chiralcel OD-H, Hexane/i-
PrOH¼90:10, 1.0 ml/min, 220 nm, tR¼8.06 min, tR¼9.48 min.
4.2.20. (S)-(ꢁ)-Acetoxy-3-phenyl-propanenitrile (2t)3. Clear oil.
26
[
d
a
]
ꢁ53.2 (c 0.67, CHCl3), 94.1% ee; 1H NMR (400 Hz, CDCl3)
D
20
4.2.13. (S)-(ꢁ)-Acetoxy-(3-nitro-phenyl)-acetonitrile (2m)9d. [
a
]
7.31–7.19 (m, 5H), 5.41 (t, J¼7.2 Hz, 1H), 3.11 (d, J¼6.8, 2H), 2.04 (s,
D
ꢁ5.6 (c 0.43, CHCl3), 91.4% ee; 1H NMR (400 Hz, CDCl3)
d
8.405–
3H); MS (EI, 70 eV) m/z: 189 (Mþ, 1), 130 (13), 129 (97), 103 (8), 91
(100), 77 (9), 73 (17), 71 (14), 69 (13), 65 (13), 60 (14), 57 (24), 55
(20), 51 (8), 43 (69), 41 (19), 39 (8), 29 (7), 28 (6); IR(film, cmꢁ1):
2969, 2925, 1750, 1650, 1537, 1497, 1455, 1372, 1217, 1091, 1036, 752,
701; Chiralcel OJ-H, Hexane/i-PrOH¼95:05, 0.4 ml/min, 220 nm,
tR¼102.43 min, tR¼122.04 min.
8.330 (m, 2H), 7.890 (d, J¼8.0 Hz, 1H), 7.692 (t, J¼8.0 Hz, 1H), 6.508
(s, 1H), 2.227 (s, 3H); MS (EI 70 eV) m/z: 193 (9), 178 (31), 161 (31),
160 (24), 134 (34), 114 (39), 88 (9), 43 (100); IR (KBr, cmꢁ1): 2917,
2848, 1757, 1576, 1535, 1467, 1430, 1352, 1207, 1091, 1029, 807, 734,
594; HPLC: Chiralcel OJ-H, Hexane/i-PrOH¼70:30, 1.0 ml/min,
254 nm, tR¼46.30 min, tR¼59.09 min.
26
4.2.21. (S)-(ꢁ)-Acetoxv-4-phenyl-butanenitrile (2u)3. Clear oil. [
a]
D
4.2.14. (S)-(ꢁ)-Acetoxy-(1-naphthyl)-acetonitrile (2n)3. Clear oil.
ꢁ27.2 (c 0.7, CHCl3), 98.8% ee; 1H NMR (400 Hz, CDCl3)
d 7.26–7.14
26
[
a]
ꢁ42.6 (c 0.53, CHCl3), 87.2% ee; 1H NMR (400 Hz, CDCl3)
d
8.02
(m, 3H), 7.11(d, J¼7.6, 2H), 5.19(t, J¼6.8,1H), 2.76 (t, J¼7.2, 2H), 2.19–
2.14(q, J¼7.2, 2H), 2.05 (s, 3H); MS (EI, 70 eV) 203 (Mþ, 2),143 (100),
116 (39), 105 (25), 91 (46), 77 (12), 73 (34), 71 (27), 65 (14), 60 (28),
57 (49), 55 (38), 51 (6), 43 (93), 41 (33); IR (film, cmꢁ1): 3015, 2969,
1738, 1434, 1365, 1216, 1092, 896; Chiralcel OD-H, Hexane/i-
PrOH¼95:05, 0.4 ml/min, 220 nm, tR¼44.39 min, tR¼52.58 min.
D
(d, J¼8.4 Hz, 1H), 7.99–7.93 (m, 2H), 7.82 (d, J¼7.2 Hz, 1H), 7.64–7.51
(m, 3H), 7.03 (s, 1H), 2.23 (s, 3H); MS (EI, 70 eV) m/z: 225 (Mþ, 26),
183 (24), 166 (64), 165 (100), 164 (17), 155 (20), 140 (17), 139 (20),
127 (18), 43 (30); IR (film, cmꢁ1): 2926, 2854, 1742, 1441, 1369, 1211,
1091, 1022, 901, 799, 773, 520; Chiralcel OJ-H, Hexane/i-
PrOH¼95:05, 0.4 ml/min, 220 nm, tR¼84.92 min, tR¼94.06 min.
4.2.22. (S)-(ꢁ)-2-Acetyloxy-undecanenitrile (2v)2i. Clear oil. [
a]
D
22.6
4.2.15. (S)-(þ)-Acetoxy-(2-naphthyl)-acetonitrile (2o)3. White sold,
ꢁ15.4 (c 0.51, CHCl3), 40.8% ee; 1H NMR (400 Hz, CDCl3)
d 5.31(t,
þ18.6 (c 0.6, CHCl3), 72.9% ee; 1H NMR
J¼6.8 Hz,1H), 2.13(s, 3H),1.92–1.86 (m, 2H),1.51–1.45 (m, 2H),1.36–
1.27 (m, 12H), 0.88(t, J¼6.8 Hz, 3H); MS (EI, 70 eV) m/z: 226 (Mþþ1,
1), 183 (9), 182 (12), 154 (7), 140 (6), 136 (11), 122 (13), 109 (12), 97
(12), 95 (26), 86 (10), 83 (13), 81 (21), 57 (12), 55 (17), 43 (100), 41
(28); IR (film, cmꢁ1): 2927, 2858, 1756, 1637, 1459, 1375, 1221, 1036;
Chiralcel OJ-H, Hexane/i-PrOH¼100:0, 0.5 ml/min, 220 nm,
tR¼20.08 min, tR¼21.64 min.
26
mp 33.8–34.5 ꢀC; [
a]
D
(400 Hz, CDCl3)
d 7.95(s, 1H), 7.94–7.79 (m, 3H), 750–7.47 (m, 3H),
6.51 (s, 1H), 2.11 (s, 3H); MS (EI, 70 eV) m/z: 225 (Mþ, 42), 183 (95),
166 (70),165 (100),164 (22),155 (19),140 (19),139 (21),127 (22), 43
(27); IR (film, cmꢁ1): 3058, 2925, 2852,1754,1602, 1509,1432,1370,
1214, 1022, 943, 894, 817, 749; Chiralcel OJ-H, Hexane/i-
PrOH¼99:01,1.0 ml/min, 220 nm, tR¼50.76 min, tR¼57.83 min.
4.2.16. (S)-(ꢁ)-Acetoxy-(2-pyridyl)-acetonitrile (2p)2l. Clear oil.
4.2.23. (S)-(ꢁ)-2-Acetoxy-(4-methyl)-pentanenitrile (2w)9c. Clear
22.9
24.2
[
a]
ꢁ10 (c 0.30, CHCl3), 54.6% ee; 1H NMR (400 Hz, CDCl3)
d
8.67
oil. [
a
]
ꢁ64.18 (c 1.7, CHCl3), 88.2% ee; 1H NMR (400 Hz, CDCl3)
D
D
(d, J¼4.8 Hz, 1H), 7.85–7.80(td, J¼1.6, 7.6 Hz, 1H), 7.55 (d, J¼7.6 Hz,
1H), 7.40–7.37 (m, 1H), 6.50(s, 1H), 2.23 (s, 3H); MS (EI, 70 eV) m/z:
176 (Mþ, 3), 134 (100), 117 (14), 106 (15), 90 (14), 79 (72), 78 (28), 51
(14), 43 (70); IR (film, cmꢁ1): 3061, 2925, 2854, 1758, 1590, 1468,
1438, 1372, 1215, 1101, 1049, 996, 967, 907, 776, 618, 571; Chiralcel
AD-H, Hexane/i-PrOH¼95:05, 1.0 ml/min, 254 nm, tR¼14.34 min,
tR¼16.61 min.
d
5.35 (t, J¼7.62, 1H), 2.14 (s, 3H), 1.88–1.76 (m, 3H), 0.98(dd, J¼4.80,
6.40, 6H); MS (EI, 70 eV) m/z: 129 (MþꢁCN,5), 113 (8), 112 (9), 99
(15), 95 (10), 94 (8), 80 (14), 71 (15), 57 (44), 43 (100), 41 (33); IR
(film, cmꢁ1): 2963, 2876, 1756, 1468, 1373, 1221, 1131, 1063, 1029,
931; Chiralcel OJ-H, Hexane/i-PrOH¼100:0, 0.5 ml/min, 220 nm,
tR¼24.85 min, tR¼27.00 min.
Acknowledgements
4.2.17. (R)-(þ)-Acetoxy-(2-furyl)-acetonitrile (2q)9b. Pale yellow oil.
[a] d 7.51
24.2 20.9(c 1.05, CHCl3), 93.0% ee; 1H NMR (400 Hz, CDCl3)
D
We are grateful to The National Natural Science Foundation of
China for financial support (Grant No. 20602007) for financial
support.
(dd, J¼0.68, 1.80 Hz, 1H), 7.69 (d, J¼3.32 Hz, 1H), 6.48 (s, 1H), 6.45
(dd, J¼1.88, 3.36 Hz, 1H), 2.17 (s, 3H); MS (EI, 70 eV) m/z: 165 (Mþ,
38), 123 (57), 106 (100), 105 (36), 95 (14), 78 (18), 77 (52), 68 (5), 51
(24), 43 (77), 28 (25); IR (film, cmꢁ1): 2917, 2849, 1732, 1575, 1539,
1466, 1090, 799; HPLC: Chiralcel AD-H, Hexane/i-PrOH¼95:05,
1.0 ml/min, 220 nm, tR¼7.37 min, tR¼8.32 min.
Supplementary data
Supplementary data includes synthetic procedures of the race-
mic substrates, 1H MNR, 19F NMR spectra, and chiral HPLC chro-
matograms. Supplementary data associated with this article can be
4.2.18. (R)-(þ)-Acetoxy-(2-thienyl)-acetonitrile (2r)9b. Clear oil.
23.2
[
d
a
]
þ11.05 (c 0.51, CHCl3), 93.38% ee; 1H NMR (400 Hz, CDCl3)
D
7.46 (dd, J¼1.02, 5.12 Hz, 1H), 7.36 (dd, J¼0.6, 3.64 Hz, 1H), 7.05
(dd, J¼3.64, 5.12 Hz,1H), 6.64 (s,1H), 2.17 (s, 3H); MS (EI, 70 eV) m/z:
181 (Mþ, 15), 139 (16), 139 (15), 122 (100), 121 (46), 111 (64), 95 (10),
83 (8), 69 (8), 58 (11), 51 (4), 45 (15), 43 (16), 39 (18), 32 (6), 28 (20);
IR(film, cmꢁ1): 3111, 2931, 2853, 1755, 1431, 1371, 1212, 1019, 941,
848, 715; HPLC: Chiralcel OJ-H, Hexane/i-PrOH¼90:10, 1.0 ml/min,
220 nm, tR¼18.38 min, tR¼19.61 min.
References and notes
1. For examples. (a) Gregory, R. J. H. Chem. Rev. 1999, 99, 3649–3682; (b) Brussee, J.;
Van der Gen, A. In Stereoselective Biocatalysis; Ramesh, N. P., Ed.; Marcel Dekker:
New York, NY, 2000; pp 289–320; (c) Effenberg, F. In Stereoselective Biocatalysis;
Ramesh, N. P., Ed.; Marcel Dekker: New York, NY, 2000; pp 321–342; (d) North,
M. Tetrahedron: Asymmetry 2003, 14, 147–176; (e) Brunel, J.-M.; Holems, I. P.
Angew Chem., Int. Ed. 2004, 43, 2752–2778; (f) Chen, F.-X.; Feng, X. Curr. Org.
Synth. 2006, 3, 77–97; (g) Roberge, C.; Fleitz, F.; Pollard, D.; Devine, P. Tetrahe-
dron: Asymmetry 2007, 18, 208–214; (h) Khan, N. H.; Kureshy, R. I.; Abdi, S. H. R.;
Agrawal, S.; Jasra, R. Coord. Chem. Rev. 2008, 252, 593–623; (i) North, M.; Usanov,
4.2.19. (S)-(ꢁ)-Acetoxy-(2-cyclohexyl)-acetonitrile (2s)9b. Clear oil.
22.5
[
d
a
]
ꢁ54.5 (c 0.52, CH2Cl2), 97.2% ee; 1H NMR (400 Hz, CDCl3)
D
5.18 (d, J¼6.0 Hz,1H), 2.15(s, 3H), 1.82(m, 6H),1.24 (m, 5H); MS (EI,